JAMES C. MULLEN - 14 Apr 2022 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
CEO, Director
Signature
/s/ James C. Mullen
Issuer symbol
EDIT
Transactions as of
14 Apr 2022
Net transactions value
$0
Form type
4
Filing time
18 Apr 2022, 16:15:11 UTC
Previous filing
04 Jan 2022
Next filing
20 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EDIT Stock Option (right to buy) Award $0 +170,989 $0.000000 170,989 14 Apr 2022 Common Stock 170,989 $45.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the vesting, upon the satisfaction of the performance criteria, of a portion of a performance-based stock option originally granted on March 2, 2021.